ASND Ascendis Pharma A/S
- 128.130
- -3.490-2.65%
- 129.750
- +1.620+1.26%
Ascendis Pharma A/S News
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(16.1%),Peter Kolchinsky(16.1%), etc.
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(7.0%)
No Data